Your browser doesn't support javascript.
loading
Incident comorbidities after tamoxifen or aromatase inhibitor therapy in a racially and ethnically diverse cohort of women with breast cancer.
Gupta, Tanya; Purington, Natasha; Liu, Mina; Han, Summer; Sledge, George; Schapira, Lidia; Kurian, Allison W.
Afiliação
  • Gupta T; Department of Medicine, Division of Medical Oncology, Stanford University, Stanford, CA, USA.
  • Purington N; Quantitative Sciences Unit, Division of Biomedical Informatics Research, Department of Medicine, Stanford University, Stanford, CA, USA.
  • Liu M; Quantitative Sciences Unit, Division of Biomedical Informatics Research, Department of Medicine, Stanford University, Stanford, CA, USA.
  • Han S; Research Informatics Center, Stanford University, Stanford, CA, USA.
  • Sledge G; Quantitative Sciences Unit, Division of Biomedical Informatics Research, Department of Medicine, Stanford University, Stanford, CA, USA.
  • Schapira L; Stanford Cancer Institute, Stanford, CA, USA.
  • Kurian AW; Department of Medicine, Division of Medical Oncology, Stanford University, Stanford, CA, USA.
Breast Cancer Res Treat ; 196(1): 175-183, 2022 Nov.
Article em En | MEDLINE | ID: mdl-36030472

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Neoplasias da Mama Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Neoplasias da Mama Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article